BIIB
Price
$190.56
Change
+$2.19 (+1.16%)
Updated
Oct 14, 01:18 PM (EDT)
16 days until earnings call
JNJ
Price
$161.58
Change
+$0.12 (+0.07%)
Updated
Oct 14, 03:20 PM (EDT)
One day until earnings call
Ad is loading...

BIIB vs JNJ

Header iconBIIB vs JNJ Comparison
Open Charts BIIB vs JNJBanner chart's image
Biogen
Price$190.56
Change+$2.19 (+1.16%)
Volume$200
CapitalizationN/A
Johnson & Johnson
Price$161.58
Change+$0.12 (+0.07%)
Volume$4.33K
CapitalizationN/A
View a ticker or compare two or three
BIIB vs JNJ Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BIIB vs. JNJ commentary
Oct 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and JNJ is a Hold.

COMPARISON
Comparison
Oct 14, 2024
Stock price -- (BIIB: $188.38 vs. JNJ: $161.46)
Brand notoriety: BIIB and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 139% vs. JNJ: 91%
Market capitalization -- BIIB: $31.34B vs. JNJ: $380.22B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 1 FA rating(s) are green whileJNJ’s FA Score has 3 green FA rating(s).

  • BIIB’s FA Score: 1 green, 4 red.
  • JNJ’s FA Score: 3 green, 2 red.
According to our system of comparison, JNJ is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 2 bearish.
  • JNJ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than JNJ.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +1.45% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

BIIB is expected to report earnings on Jan 30, 2025.

JNJ is expected to report earnings on Jan 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than BIIB($31.3B). JNJ has higher P/E ratio than BIIB: JNJ (30.34) vs BIIB (26.95). JNJ YTD gains are higher at: 5.427 vs. BIIB (-27.202). JNJ has higher annual earnings (EBITDA): 23.3B vs. BIIB (2.04B). JNJ has more cash in the bank: 22.9B vs. BIIB (1.05B). BIIB has less debt than JNJ: BIIB (7.34B) vs JNJ (29.3B). JNJ has higher revenues than BIIB: JNJ (85.2B) vs BIIB (9.84B).
BIIBJNJBIIB / JNJ
Capitalization31.3B380B8%
EBITDA2.04B23.3B9%
Gain YTD-27.2025.427-501%
P/E Ratio26.9530.3489%
Revenue9.84B85.2B12%
Total Cash1.05B22.9B5%
Total Debt7.34B29.3B25%
FUNDAMENTALS RATINGS
BIIB vs JNJ: Fundamental Ratings
BIIB
JNJ
OUTLOOK RATING
1..100
5150
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
10024
SMR RATING
1..100
7720
PRICE GROWTH RATING
1..100
6352
P/E GROWTH RATING
1..100
1884
SEASONALITY SCORE
1..100
4750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (16) in the Pharmaceuticals Major industry is significantly better than the same rating for BIIB (96) in the Biotechnology industry. This means that JNJ’s stock grew significantly faster than BIIB’s over the last 12 months.

JNJ's Profit vs Risk Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for BIIB (100) in the Biotechnology industry. This means that JNJ’s stock grew significantly faster than BIIB’s over the last 12 months.

JNJ's SMR Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for BIIB (77) in the Biotechnology industry. This means that JNJ’s stock grew somewhat faster than BIIB’s over the last 12 months.

JNJ's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as BIIB (63) in the Biotechnology industry. This means that JNJ’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's P/E Growth Rating (18) in the Biotechnology industry is significantly better than the same rating for JNJ (84) in the Pharmaceuticals Major industry. This means that BIIB’s stock grew significantly faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBJNJ
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
53%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
49%
MACD
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
45%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
42%
Advances
ODDS (%)
Bullish Trend 5 days ago
54%
Bullish Trend 6 days ago
43%
Declines
ODDS (%)
Bearish Trend 7 days ago
67%
Bearish Trend 8 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
51%
Aroon
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
39%
View a ticker or compare two or three
Ad is loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
BTC.X62851.375000-341.648440
-0.54%
Bitcoin cryptocurrency
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.11%
AMGN - BIIB
42%
Loosely correlated
+2.29%
OGN - BIIB
36%
Loosely correlated
+0.11%
GILD - BIIB
33%
Loosely correlated
+0.33%
AZN - BIIB
31%
Poorly correlated
+0.62%
PFE - BIIB
30%
Poorly correlated
-0.61%
More